Financial Support

RABBIT is financially supported by a joint grant from all companies that provide biologic DMARDs for therapy of rheumatoid arthritis. The sponsorship is unconditional; therefore, solely the principle investigators and the scientific advisory board are responsible for data acquisition and analysis as well as for publication of results; the drug manufacturers have no influence over this.

AbbVie Deutschland GmbH & Co. KG
Amgen GmbH
Bristol-Myers Squibb GmbH & Co. KGaA
Celltrion Inc.
Fresenius Kabi SwissBioSim GmbH
Hexal AG
Lilly Deutschland GmbH
MSD Sharp & Dohme GmbH
Pfizer Pharma GmbH
Roche Pharma AG
Samsung Bioepis Co., Ltd.
Sanofi-Aventis Deutschland GmbH
Swedish Orphan Biovitrum (vorher Amgen) (bis 2012)
UCB Biosciences GmbH